Tiziana Life Sciences Ltd
TLSA · NASDAQ
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$5,632 | -$5,761 | -$3,677 | -$7,181 |
| Dep. & Amort. | $88 | $49 | $50 | $32 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$1,696 | -$1,787 | $1,330 | $2,854 |
| Other Non-Cash | $417 | $5,960 | $2,613 | $887 |
| Operating Cash Flow | -$6,823 | -$1,539 | $316 | -$3,408 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$6 | -$4 | -$11 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | -$791 |
| Inv. Sales/Matur. | $2,886 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$42 | $0 | $1 |
| Investing Cash Flow | $2,880 | -$46 | -$11 | -$791 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $7,408 | $3,713 | $0 | $126 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$48 | -$58 | -$55 | -$65 |
| Financing Cash Flow | $7,360 | $3,655 | -$55 | $61 |
| Forex Effect | $110 | $2 | -$292 | -$147 |
| Net Chg. in Cash | $3,527 | $2,073 | -$42 | -$4,284 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $3,724 | $903 | $935 | $5,221 |
| End Cash | $7,251 | $2,976 | $893 | $936 |
| Free Cash Flow | -$6,829 | -$1,543 | $305 | -$3,408 |